https://www.hypopara.org/ 2026-04-10T11:20:01-04:00 weekly 0.5 https://www.hypopara.org/about 2025-06-05T11:42:48-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism 2024-09-04T18:38:47-04:00 weekly 0.5 https://www.hypopara.org/how-to-help 2024-09-04T18:39:11-04:00 weekly 0.5 https://www.hypopara.org/resources 2024-09-04T18:39:52-04:00 weekly 0.5 https://www.hypopara.org/news-events 2024-09-04T18:40:12-04:00 weekly 0.5 https://www.hypopara.org/partners 2026-03-13T13:52:50-04:00 weekly 0.5 https://www.hypopara.org/contact 2024-06-26T08:44:07-04:00 weekly 0.5 https://www.hypopara.org/search-results 2023-05-19T17:19:09-04:00 weekly 0.5 https://www.hypopara.org/privacy-policy 2024-01-28T21:23:26-05:00 weekly 0.5 https://www.hypopara.org/terms-conditions 2023-05-19T17:18:26-04:00 weekly 0.5 https://www.hypopara.org/about/board-directors 2025-06-09T21:17:25-04:00 weekly 0.5 https://www.hypopara.org/about/medical-advisors 2025-09-22T13:36:32-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/symptoms-treatment 2025-09-22T15:33:40-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/types-causes 2026-03-10T20:21:43-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories 2025-08-29T18:24:21-04:00 weekly 0.5 https://www.hypopara.org/how-to-help/join-our-community 2024-06-26T08:41:23-04:00 weekly 0.5 https://www.hypopara.org/how-to-help/donate 2023-07-17T19:32:39-04:00 weekly 0.5 https://www.hypopara.org/how-to-help/volunteer 2024-06-26T08:40:37-04:00 weekly 0.5 https://www.hypopara.org/how-to-help/advocacy 2025-03-24T10:30:32-04:00 weekly 0.5 https://www.hypopara.org/resources/patient-recommended-doctors 2024-06-26T08:45:17-04:00 weekly 0.5 https://www.hypopara.org/resources/important-links-downloads 2025-09-22T15:39:25-04:00 weekly 0.5 https://www.hypopara.org/resources/clinical-trials-research 2026-01-26T13:38:32-05:00 weekly 0.5 https://www.hypopara.org/resources/social-security-disability-information 2023-06-22T15:44:17-04:00 weekly 0.5 https://www.hypopara.org/resources/frequently-asked-questions 2023-06-22T15:51:11-04:00 weekly 0.5 https://www.hypopara.org/news-events/news 2026-03-13T10:33:37-04:00 weekly 0.5 https://www.hypopara.org/news-events/events 2023-08-10T11:57:24-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/newly-diagnosed 2025-09-22T15:14:24-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/aris-story 2023-05-22T10:48:35-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/mirrandas-story 2023-06-23T12:05:27-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/loris-story 2023-05-22T10:53:27-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/peaces-story 2023-05-22T10:51:37-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/travis-story 2023-05-22T10:50:03-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/kellys-story 2023-05-22T10:46:51-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/carols-story 2023-05-22T10:28:50-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/lynettes-story 2023-05-22T10:27:14-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/baris-story 2023-05-19T10:33:51-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/barbaras-story 2023-05-19T10:32:28-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/antonias-story 2023-05-19T10:30:53-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/bridgets-story 2023-05-19T10:29:13-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/ediths-story 2023-05-18T14:25:25-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/kims-story 2023-05-18T14:19:56-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/james-story 2023-05-17T16:42:54-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/pattys-story 2023-05-17T16:41:34-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/micheles-story 2023-05-17T16:39:25-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/bobs-story 2023-05-17T16:35:43-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/pams-story 2025-08-29T18:10:59-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/craigs-story 2023-05-17T16:26:11-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/natpara-discontinuation-statement-dr-mannstadt 2023-05-18T13:12:35-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/26th-international-thyroid-cancer-survivors-conference-2023 2023-08-10T11:45:02-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/priority-review-ascendis-pharmas-nda-transcontm-pth 2023-06-22T14:45:13-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/world-hypoparathyroidism-awareness-day 2023-06-23T12:08:22-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/bridgebio-pharma-announces-updated-phase-2b-data-encaleret-adh1 2023-05-19T15:05:55-04:00 weekly 0.5 https://www.hypopara.org/resources/past-webinars-conferences 2026-03-13T10:35:23-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/hypoparathyroidism-association-annual-meeting-2023 2023-11-04T08:10:12-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/know-your-rights-pamphlet-released-aimed-alliance-and-hypoparathyroidism-assoc 2023-07-20T19:19:02-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/pfdd 2024-03-15T13:07:48-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/ascendis-press-release 2023-09-07T22:10:45-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/https-investors-ascendispharma-com-news-releases-news-release-details-ascendis-pharma-receives-positive-chmp-opinion-transcontm 2023-09-24T17:01:36-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/calcilytix-bridgebio-company-enrolling-people-ages-16-years-or-older-their-phase-3-clinical-study-calibrate 2023-09-26T22:53:33-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/amolyt-pharma-present-data-renal-effects-eneboparatide 2023-09-28T11:26:31-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/amolyt-pharma-announces-two-poster-presentations-american-society-bone-and-mineral-research-asbmr-2023-annual-meeting 2023-10-03T22:57:12-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/bridgebio-pharma-announces-new-england-journal-medicine-publication 2023-10-13T23:31:51-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/nih-study-post-surgical-patients 2023-10-15T15:27:28-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/hypoparathyroidism-survey 2023-10-31T00:17:09-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/ascendis-pharma-announces-timing-third-quarter-2023-financial-results-and-transcon-pth-nda-resubmission 2023-11-01T21:32:13-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/amolyt-pharma-name-biotech-company-year 2023-11-17T08:09:05-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/amolyt-pharma-cmo-mark-sumeray-joined-biotechnation-podcast-about-hypoparathyroidism 2023-11-17T08:16:03-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/mbx-biosciences-announces-positive-phase-1-results-their-drug-hypoparathyroidism 2023-11-17T08:18:27-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/ascendis-pharma-announces-approval-yorvipath-european-commission 2023-11-20T22:05:06-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/specialised-therapeutics-signs-exclusive-agreement-ascendis-pharma 2024-01-14T22:06:41-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/https-www-sciencedirect-com-science-article-abs-pii-S0003426623000781-fbclid-IwAR0BzD3g12C2qJiSorHDnKLhUWcGTMhcrEWkOrzsu59pe8A3i 2024-03-13T14:28:16-04:00 weekly 0.5 https://www.hypopara.org/el-pfdd 2024-12-11T14:30:33-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/phase-2-study-eneboparatide-results-have-been-published 2024-03-13T14:52:19-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/amolyt-pharma-enters-definitive-agreement-be-acquired-astrazeneca 2024-03-18T09:29:30-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/bridgebio-shares-data-shows-adh1-common-genetic-form-hypoparathyroidism 2024-03-19T12:41:45-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/2024-1st-quarter-newsletter 2024-04-01T18:19:49-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/2024-conference 2024-10-17T14:42:19-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/evolving-landscape-managing-hypoparathyroidism 2024-04-15T17:03:30-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/statnews-article-about-hypoparathyroidism 2024-04-23T10:50:33-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/public-service-announcement-about-hypoparathyro 2024-04-29T22:35:40-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/amolyt-pharma-granted-fda-fast-track-designation-eneboparatide-treatment-hypoparathyroidism 2024-05-02T09:08:52-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/newsletter-world-hypopara-day-edition 2024-05-19T09:49:13-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/ascendis-pharma-shares-renal-function-results-phase-3-trial 2024-05-13T19:13:28-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/ascendis-pharma-announces-extension-us-food-and-drug-administration-review-period-transcontm-pth-adults-hypoparathyroidism 2024-05-14T18:39:47-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/world-hypopara-day 2024-05-28T14:27:49-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/women-wellness-michele-rayes-hypoparathyroidism-association 2024-05-28T20:49:23-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/optimizing-outcomes-comprehensive-approaches-recognizing-diagnosing-and-managing-hypoparathyroidism 2024-06-18T20:14:41-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/mbx-biosciences-launches-phase-2-drug-trial 2024-06-19T13:58:25-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/endocrine-society-article-about-using-pth-therapy-pump 2024-06-20T15:23:58-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/hypopara-2nd-quarter-newsletter 2024-06-28T08:30:46-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/astrazeneca-closes-acquisition-amolyt-pharma 2024-07-15T06:52:45-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/letter-leadership-alexion-and-amolyt 2024-07-16T13:53:50-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/septerna-secures-150-dollars-million-series-b-financing-advance-pipeline-novel-gpcr-targeted-medicines 2024-07-17T08:44:45-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/dolores-story 2026-01-09T15:08:28-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/transcon-pth-now-known-yorvipath-has-recieved-fda-approval 2024-09-04T18:23:02-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/avail-trial-has-new-sites-open 2024-08-16T12:27:25-04:00 weekly 0.5 https://www.hypopara.org/partners/Alexion-AstraZeneca-Rare-Disease 2025-08-13T12:09:58-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/updates-pbm-hearing 2024-08-28T17:45:55-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/mbx-biosciences-updates-trial-site-availability-their-avail-trial 2024-08-28T17:53:40-04:00 weekly 0.5 https://www.hypopara.org/partners/take 2025-12-03T11:56:45-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/ascendis-investor-call-and-announcement-their-asap-program 2024-09-03T18:24:56-04:00 weekly 0.5 https://www.hypopara.org/partners/bridgebiocalcilytix 2026-03-10T20:24:27-04:00 weekly 0.5 https://www.hypopara.org/partners/ascendis 2026-01-22T13:43:40-05:00 weekly 0.5 https://www.hypopara.org/partners/mbx-biosciences 2025-08-13T11:32:41-04:00 weekly 0.5 https://www.hypopara.org/partners/septerna 2025-08-13T11:49:14-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/ascendis-pharma-receives-orphan-drug-exclusivity-us-yorvipath-r-palopegteriparatide-treatment-hypoparathyroidism-adults 2024-09-12T10:22:19-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/q3-newsletter 2024-10-10T21:22:09-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/2024-conference/live 2024-11-08T19:47:28-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/yorvipath-be-available-us-mid-january 2024-11-14T17:17:46-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/mbx-biosciences-announces-mbx-2109-phase-1-study-results 2024-12-03T11:35:12-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/yorvipath-ready-be-prescribed 2024-12-19T08:50:40-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/4th-quarter-newsletter 2024-12-21T11:28:37-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/yorvipath-launches-2-new 2025-01-30T18:45:54-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/assistance-fund-taf-launches-program-hypopara 2025-02-09T15:13:57-05:00 weekly 0.5 https://www.hypopara.org/news-events/events/fda-nih-rare-disease-day-feb-27-28 2025-02-09T16:04:54-05:00 weekly 0.5 https://www.hypopara.org/news-events/events/international-hypoparathyroidism-conference 2025-09-26T16:22:34-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/bridgebio-announces-completion-their-phase-3-calibrate-study-adh1 2025-02-17T09:16:43-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/septerna-announces-discontinuation-sep-786 2025-02-19T17:39:41-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/adh1-podcast 2025-03-07T08:38:03-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/hypoparathyroidism-association-joins-cords 2025-03-13T12:45:08-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/beyond-calcium-holistic-approach-optimizing-outcomes-patients-hypoparathyroidism 2025-03-16T10:03:41-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/2025-q1-newsletter 2025-03-24T14:52:51-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/james-sanders-legacy-award-scholarship 2025-04-07T12:55:54-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/james-sanders-legacy-scholarship 2025-04-07T13:02:32-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/hypopara-surveys 2025-04-11T10:06:14-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/world-hypopara-day-1 2025-05-17T18:48:46-04:00 weekly 0.5 https://www.hypopara.org/partners/orsini 2025-09-30T10:03:32-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/survey-specific-adh1-patients-and-caregivers 2025-06-16T13:51:23-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/new-french-website-hypopara-patients 2025-05-28T19:28:54-04:00 weekly 0.5 https://www.hypopara.org/what-is-hypoparathyroidism/patient-stories/desirres-story 2025-09-22T13:45:25-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/opportunity-adolescents-hypoparathyroidism 2025-06-08T13:04:30-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/2025-q2-newsletter 2025-06-30T13:49:28-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/new-standard-care-guidelines-have-been-published 2025-09-18T13:15:36-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/mbx-biosciences-breaking-news 2025-09-22T06:59:22-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/international-hypoparathyroidism-conference/conference-live-stream 2025-10-08T23:34:58-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/webinar 2025-10-07T15:14:36-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/2025-q3-newsletter 2025-09-23T21:58:04-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/international-hypoparathyroidism-conference/conference-live-stream-day-2 2025-09-23T23:19:52-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/international-hypoparathyroidism-conference/conference-live-stream-keynote 2025-10-04T19:37:24-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/international-hypoparathyroidism-conference/conference-live-stream-day-3 2025-09-23T23:26:15-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/international-hypoparathyroidism-conference 2025-10-06T14:40:54-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/new-hypoparathyroidism-treatment-could-provide-hope-patients 2025-10-21T11:13:35-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/webinar/webinar-stream 2025-10-22T17:37:43-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/bridgebio-reports-positive-phase-3-topline-results-encaleret-patients-autosomal-dominant-hypocalcemia-type-1 2025-11-03T21:25:43-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/missing-metrics-navigating-symptom-fluctuations-hypopara-care-women 2025-12-05T08:39:03-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/yorvipath-live-event 2025-12-05T09:03:53-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/new-trial-allotransplantation-parathyroid-allotransplant-treatment-hypoparathyroidism-patth 2025-12-15T08:33:14-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/q4-2026-newsletter 2025-12-17T20:38:40-05:00 weekly 0.5 https://www.hypopara.org/news-events/events/patth-webinar 2026-01-12T22:42:28-05:00 weekly 0.5 https://www.hypopara.org/news-events/events/introduction-yorvipath-event 2026-01-13T00:48:51-05:00 weekly 0.5 https://www.hypopara.org/news-events/events/rare-disease-day 2026-01-12T23:09:23-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/beyond-adrenal-crisis-protean-manifestations-hypocalcemia-autoimmune-polyglandular-syndrome-type-1 2026-01-13T00:30:03-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/fahrs-syndrome-secondary-hypoparathyroidism-presenting-neurological-and-cardiac-manifestations 2026-01-26T16:16:17-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/marabou-feather-wing-sign 2026-01-26T13:53:34-05:00 weekly 0.5 https://www.hypopara.org/news-events/news/hypopara-unscrip 2026-03-16T09:19:18-04:00 weekly 0.5 https://www.hypopara.org/news-events/news/2026-1st-quarter-newsletter 2026-03-15T21:58:53-04:00 weekly 0.5 https://www.hypopara.org/news-events/events/tralyte-health-webinar 2026-04-09T10:09:44-04:00 weekly 0.5